## The Cost-Effectiveness of RSV Vaccination for Older Adults: A Public Health Perspective Recent research from the University of Michigan has shed light on the cost-effectiveness of the newly approved respiratory syncytial virus (RSV) vaccines for older adults. This study, conducted in collaboration with the Centers for Disease Control and Prevention (CDC), highlights the potential […]